Dr. Reddy’s Q2 FY24 financial results show 9% YoY revenue growth

Pallavi Madhiraju- October 27, 2023 0

Dr. Reddy’s Laboratories Ltd., an Indian pharma major, has unveiled its robust performance metrics for the Q2 FY24, ending September 30, 2023. Under the guidelines ... Read More

Dr. Reddy’s Laboratories Q1 FY22 profit down by 1% to Rs 571cr

pallavi123- July 27, 2021 0

Dr. Reddy’s Laboratories has reported a 1% drop in its profit after tax for the first quarter of the fiscal year 2022 (Q1 FY22) to ... Read More

Dr. Reddy’s launches Sputnik V Covid vaccine in India at Rs 995 per dose

pallavi123- May 14, 2021 0

Dr. Reddy's Laboratories has launched the Sputnik V Covid vaccine in India with the first dose of the Russian vaccine administered today in Hyderabad. The ... Read More

Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI

pallavi123- February 22, 2021 0

Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from ... Read More

Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine

pharmanewsdaily- January 16, 2021 0

Dr. Reddy’s Laboratories has secured the go-ahead from the Drugs Control General of India (DCGI) to begin phase 3 clinical trial for the Russian Covid-19 ... Read More

Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V

pharmanewsdaily- January 14, 2021 0

Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India ... Read More

Dr. Reddy’s, RDIF to bring Sputnik V coronavirus vaccine to India

pharmanewsdaily- September 17, 2020 0

Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories have agreed to cooperate on clinical trials and distribution of the Sputnik V coronavirus vaccine in ... Read More